Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
18 p, 12.1 MB Depositional evolution and models for a deep-lacustrine gravity flow system in a half-graben rifted sag, Beibuwan Basin, South China Sea / Li, Yuan (China Earthquake Administration. Institute of Seismology. Key Laboratory of Earthquake Geodesy) ; Wang, Hua (China University of Geosciences) ; Zhu, Jie Qiong (China Southern Petroleum Exploration & Development Corporation) ; Zhang, Guo Tao (Chinese Academy of Geological Sciences. Wuhan Institute of Geology and Mineral Resources) ; Guo, Hao (China Southern Petroleum Exploration & Development Corporation) ; Li, Xiao Han (China Southern Petroleum Exploration & Development Corporation) ; Lin, Song (China Earthquake Administration. Institute of Seismology. Key Laboratory of Earthquake Geodesy. Wuhan Institute of Earthquake Engineering Co., Ltd) ; Min, Jin (China Earthquake Administration. Institute of Seismology. Key Laboratory of Earthquake Geodesy)
The Paleogene Liushagang Formation is part of the Fushan Sag, a continental lacustrine basin located at the Southeastern margin of the Beibuwan Basin, South China Sea. Further understanding of the deep-water gravity flow deposits in this formation will be conducive to lithologic reservoir exploration in the sag. [...]
2022 - 10.1344/GeologicaActa2022.20.3
Geologica acta, Vol. 20 (2022) , p. 1-18 (Articles)  
2.
13 p, 2.0 MB Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer / Garrido-Castro, Ana (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Saura, Cristina (SOLTI Breast Cancer Research Group, Barcelona) ; Barroso-Sousa, Romualdo (Present Address: Hospital Sírio-Libanês, Brasilia, Brazil) ; Guo, Hao (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Data Sciences) ; Ciruelos, Eva (Hospital Universitario 12 de Octubre (Madrid)) ; Bermejo, Begoña (Centro de Investigación Biomédica en Red de Cáncer) ; Gavilá, Joaquin (Fundació Institut Valencià d'Oncologia) ; Serra, Violeta (Vall d'Hebron Institut d'Oncologia) ; Prat, Aleix (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Paré Brunet, Laia (SOLTI Breast Cancer Research Group) ; Céliz, Pamela (SOLTI Breast Cancer Research Group) ; Villagrasa, Patricia (SOLTI Breast Cancer Research Group) ; Li, Yisheng (The University of Texas MD Anderson Cancer Center. Department of Biostatistics, Division of Basic Sciences) ; Savoie, Jennifer (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Xu, Zhan (Northern Arizona University. School of Communication) ; Arteaga, Carlos L. (UT Southwestern Medical Center. Harold C. Simmons Comprehensive Cancer Center) ; Krop, Ian E. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Solit, David B. (Memorial Sloan Kettering Cancer Center) ; Mills, Gordon B. (The University of Texas MD Anderson Cancer Center. Present Address: Division of Basic Science Research, Department of Systems Biology) ; Cantley, Lewis C. (Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College) ; Winer, Eric P. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Lin, Nancy U. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Rodon, Jordi (The University of Texas MD Anderson Cancer Center. Present Address: Department of Investigational Cancer Therapeutics) ; Universitat Autònoma de Barcelona
Treatment options for triple-negative breast cancer remain limited. Activation of the PI3K pathway via loss of PTEN and/or INPP4B is common. Buparlisib is an orally bioavailable, pan-class I PI3K inhibitor. [...]
2020 - 10.1186/s13058-020-01354-y
Breast cancer research, Vol. 22 (november 2020)  

See also: similar author names
1 Guo, Hongbo
2 Guo, Hui
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.